Opposing effects of dietary n-3 and n-6 fatty acids on mammary carcinogenesis: The Singapore Chinese Health Study

por Gago-Dominguez, M, Yuan, J-M, Sun, C-L, Lee, H-P, Yu, M C
Publicado 2003

A novel approach in the treatment of neuroendocrine gastrointestinal tumours. Targeting the epidermal growth factor receptor by gefitinib (ZD1839)

por Höpfner, M, Sutter, A P, Gerst, B, Zeitz, M, Scherübl, H
Publicado 2003

Anti-inflammatory and anti-invasive effects of α-melanocyte-stimulating hormone in human melanoma cells

por Eves, P, Haycock, J, Layton, C, Wagner, M, Kemp, H, Szabo, M, Morandini, R, Ghanem, G, García-Borrón, J C, Jiménez-Cervantes, C, Mac Neil, S
Publicado 2003

Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome P450 3A4 substrate, in patients with chronic myeloid leukaemia

por O'Brien, S G, Meinhardt, P, Bond, E, Beck, J, Peng, B, Dutreix, C, Mehring, G, Milosavljev, S, Huber, C, Capdeville, R, Fischer, T
Publicado 2003

Plasma concentrations of 5-fluorouracil and F-β-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protra...

por Yamada, Y, Hamaguchi, T, Goto, M, Muro, K, Matsumura, Y, Shimada, Y, Shirao, K, Nagayama, S
Publicado 2003

Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma

por Mabed, M, El-Helw, L, Shamaa, S
Publicado 2004

Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer

por Gori, S, Colozza, M, Mosconi, A M, Franceschi, E, Basurto, C, Cherubini, R, Sidoni, A, Rulli, A, Bisacci, C, Angelis, V De, Crinò, L, Tonato, M
Publicado 2004

Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status

por Mirjolet, J-F, Barberi-Heyob, M, Didelot, C, Peyrat, J-P, Abecassis, J, Millon, R, Merlin, J-L
Publicado 2000

Low expression of bcl-2 in Brca1-associated breast cancers

por Freneaux, P, Stoppa-Lyonnet, D, Mouret, E, Kambouchner, M, Nicolas, A, Zafrani, B, Vincent-Salomon, A, Fourquet, A, Magdelenat, H, Sastre-Garau, X
Publicado 2000

Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases

Publicado 2000

Exposure to power frequency electric fields and the risk of childhood cancer in the UK

por Skinner, J, Mee, T J, Blackwell, R P, Maslanyj, M P, Simpson, J, Allen, S G, Day, N E
Publicado 2002

Phase II study of irinotecan with bolus and high dose infusional 5-FU and folinic acid (modified de Gramont) for first or second line treatment of advanced or metastatic colorectal...

por Leonard, P, Seymour, M T, James, R, Hochhauser, D, Ledermann, J A
Publicado 2002

The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer

por Yousef, G M, Scorilas, A, Magklara, A, Memari, N, Ponzone, R, Sismondi, P, Biglia, N, Abd Ellatif, M, Diamandis, E P
Publicado 2002

Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosis

por Strojan, P, Oblak, I, Svetic, B, Šmid, L, Kos, J
Publicado 2004

Why does specialist treatment of breast cancer improve survival? The role of surgical management

por Kingsmore, D, Hole, D, Gillis, C
Publicado 2004

CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients

por Pujol, J-L, Molinier, O, Ebert, W, Daurès, J-P, Barlesi, F, Buccheri, G, Paesmans, M, Quoix, E, Moro-Sibilot, D, Szturmowicz, M, Bréchot, J-M, Muley, T, Grenier, J
Publicado 2004

In vivo evaluation of [(18)F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography

por Barthel, H, Wilson, H, Collingridge, D R, Brown, G, Osman, S, Luthra, S K, Brady, F, Workman, P, Price, P M, Aboagye, E O
Publicado 2004

Overexpression of dopa decarboxylase in peritoneal dissemination of gastric cancer and its potential as a novel marker for the detection of peritoneal micrometastases with real-tim...

por Sakakura, C, Takemura, M, Hagiwara, A, Shimomura, K, Miyagawa, K, Nakashima, S, Yoshikawa, T, Takagi, T, Kin, S, Nakase, Y, Fujiyama, J, Hayasizaki, Y, Okazaki, Y, Yamagishi, H
Publicado 2004

Declining mortality from breast cancer in Yorkshire, 1983–1998: extent and causes

por Pisani, P, Forman, D
Publicado 2004

Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studie...

por Body, J J, Diel, I J, Lichinitzer, M, Lazarev, A, Pecherstorfer, M, Bell, R, Tripathy, D, Bergstrom, B
Publicado 2004